Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs), which are known to be cyclooxygenase (COX) inhibitors, have been reported to exert anti-proliferative and pro-apoptotic effects on a variety of cancer cells. Since the COX-2 isoform was found to be overexpressed in a many human cancers, a particular attention was paid on the possible use of selective COX-2 inhibitors in cancer chemoprevention. The present review focuses on the state of the art in cancer research developed with COX-2 preferential/selective inhibitors belonging to the family of N-arylmethanesulfonamides, in particular nimesulide and NS-398.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152006776930855
2006-05-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152006776930855
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test